Recent News

• 04.29.2025 - Q1 2025 Incyte Corporation Earnings Conference Call
• 04.25.2025 - Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 2025
• 04.23.2025 - Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
• 04.10.2025 - Incyte to Report First Quarter Financial Results
• 04.07.2025 - Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.17.2025 - Incyte Investor Call
• 03.17.2025 - Incyte Announces Positive Topline Results From Two Phase 3 Clinical Trials of Povorcitinib in Patients With Hidradenitis Suppurativa

Recent Filings

• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities